Ligand validation:5UHW

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5UHW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5UHW_NAD_B_401	92%	46%	0.083	0.975	0.83	1.28	2	7	0	0	100%	1
5UHW_NAD_A_401	90%	45%	0.09	0.974	0.82	1.33	1	7	0	0	100%	1
5UI9_NAD_A_401	86%	48%	0.102	0.971	0.8	1.23	1	6	0	0	100%	1
5UHZ_NAD_A_401	70%	46%	0.144	0.964	0.83	1.26	1	7	0	0	100%	1
5UIA_NAD_B_401	61%	44%	0.151	0.942	0.82	1.38	1	9	0	0	100%	1
5UIB_NAD_B_401	60%	45%	0.169	0.957	0.81	1.34	2	6	0	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.